Literature DB >> 8675973

Isoniazid, tricyclics and the "cheese reaction".

A DiMartini1.   

Abstract

Isoniazid is an antitubercular drug with some monamine oxidase (MAO) inhibition. Perhaps because this is only weak inhibition, a few clinicians consider dietary or drug restrictions for their patients on isoniazid. However recent reports suggest the combination of isoniazid and antidepressants may cause adverse events possibly related to isoniazid's MAO inhibition activity. The mechanism of the tyramine reaction and recommendations for cautious combinations of tricyclic antidepressants and isoniazid are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675973     DOI: 10.1097/00004850-199510030-00009

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  3 in total

1.  Risk of Serotonin Syndrome with Isoniazid.

Authors:  Michael E O'Brien; Ronak G Gandhi; Camille N Kotton; Meagan L Adamsick
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

Authors:  Thomas M Polasek; David J Elliot; Andrew A Somogyi; Elizabeth M J Gillam; Benjamin C Lewis; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

Review 3.  Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.

Authors:  Cenk Tek
Journal:  Patient Prefer Adherence       Date:  2016-05-04       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.